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Edited by Ga´spa´r Je´kelyAbstract Protein phosphatase 4 (Ppp4) is a ubiquitous serine/
threonine phosphatase in the PPP family that is now recognised
to regulate a variety of cellular functions independently of pro-
tein phosphatase 2A (PP2A). Regulatory subunits (R1 and R2)
have been identiﬁed in mammals that interact with the catalytic
subunit of Ppp4 (Ppp4c) and control its activity. Ppp4c–R2 com-
plexes play roles in organelle assembly; not only are they essen-
tial for maturation of the centrosome, but they are also involved
in spliceosomal assembly via interaction with the survival of mo-
tor neurons (SMNs) complex. Several cellular signalling routes,
including NF-jB and the target of rapamycin (TOR) pathways
appear to be regulated by Ppp4. Emerging evidence indicates
that Ppp4 may play a role in the DNA damage response and that
Ppp4c–R1 complexes decrease the activity of a histone deacetyl-
ase, implicating Ppp4 in the regulation of chromatin activities.
Antitumour agents, cantharidin and fostriecin, potently inhibit
the activity of Ppp4. Orthologues of mammalian Ppp4 subunits
in Saccharomyces cerevisiae confer resistance to the anticancer,
DNA-binding drugs, cisplatin and oxaliplatin.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Over a decade and a half since its discovery, protein phos-
phatase 4 (Ppp4/PP4/PPX) has now gained recognition as a
ubiquitous protein phosphatase that removes phosphate from
serine and threonine in proteins and regulates many cellular
functions independently of other related protein phosphatases
in the PPP family [1]. Current interest in this phosphatase re-
sides not only in the fact that the catalytic subunit (Ppp4c) is
essential for centrosome maturation in Drosophila melanogas-
ter and Caenorhabditis elegans [2,3], but also that its ortho-
logue in Saccharomyces cerevisiae (Pph3p) participates in the
nutrient sensing pathway [4] and confers resistance to the anti-
cancer DNA-binding agents cisplatin and oxaliplatin [5]. This
review collates the experimental data from diﬀerent organisms
in order to explore the crucial and intriguing roles that Ppp4
may play in cellular signalling and regulation.*Corresponding author. Fax: +44 0 1382 223778.
E-mail address: p.t.w.cohen@dundee.ac.uk (P.T.W. Cohen).
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doi:10.1016/j.febslet.2005.04.0702. Relationship of protein phosphatase 4 to other members of the
PPP family
2.1. Ppp4 catalytic subunit
Mammalian Ppp4c was predicted from several cDNAs
and its 65% amino acid identity to PP2Aca and PP2Acb
isoforms and extremely high conservation to D. melanogaster
(94% amino acid identity) suggested that it was likely to
have distinct cellular roles from PP2A [2,6–8]. However,
identiﬁcation of a putative orthologue (Pph3p) in S. cerevi-
siae, which was non-essential and had overlapping function
with the PP2A orthologues (Pph21p and Pph22p), allowing
limited growth when their genes were deleted [9,10] queried
this supposition. Ppp4c and Pph3 contain all the conserved
motifs indicative of the PPP family of protein serine/threo-
nine phosphatases [11] and their position within the PP2A
subfamily shows that they are also fairly closely related to
human Ppp6, D. melanogaster PPV-6A and S. cerevisiae
Sit4 (Fig. 1), which form a cluster now known to be func-
tional orthologues [12,13]. Despite the fact that the crystal
structures of PP1c and calcineurin/PP2B have been known
for 10 years, Ppp4c, PP2Ac and Ppp6c have not been ex-
pressed in suﬃcient quantities for crystallisation. The latter
three phosphatase catalytic subunits, uniquely among the
PPP family, undergo reversible methyl esteriﬁcation at their
carboxy-termini, a covalent modiﬁcation that modulates
their interactions with regulatory subunits [14,15].2.2. Protein phosphatase 4 interacting proteins and orthologues
The interplay between the diﬀerent regulatory subunits of
Ppp4c is likely to be central to the mode of action of Ppp4.
Ppp4c exists in high molecular mass complexes (450–
600 kDa) in mammalian tissues and puriﬁcation of two
Ppp4 complexes has uncovered two structurally distinct reg-
ulatory subunits of Ppp4c, termed R1 and R2 that do not
interact with PP2Ac (Table 1). R1 (105 kDa) contains 14
‘‘heat’’ repeats that are similar to those found in the A reg-
ulatory subunit of PP2A [16]. An R1 isoform, termed RMEG
with a small insertion near the N-terminus that probably
arises from alternative mRNA splicing has also been re-
ported [17]. R2 is a highly asymmetric protein with calcu-
lated molecular mass of 55 kDa and an elution position
from Sepharose columns corresponding to 450 kDa [18]. In
contrast, a regulatory subunit, a4 (39 kDa, originally identi-
ﬁed in association with Ig-a, a component of the B-cell
receptor complex) dimerises with protein phosphatase cata-
lytic subunits of Ppp4, PP2A and Ppp6 [19,20]. a4 isation of European Biochemical Societies.
Table 1
Protein phosphatase 4 subunits and their orthologues in diﬀerent organisms
Subunit type Human D. melanogaster S. cerevisiae References
Catalytic subunit Ppp4c (35) PPP4c (35) Pph3p (35) [2,6,9]
Core regulatory subunit R1 (105) [16]
Core regulatory subunit R2 (55) R2 (67) R2/YBL046w (51) [18]
Regulatory subunit shared with PP2A/Pph3p a4 (39) Tap-42/CG31852 (43) Tap42p (42) [19–21]
Variable third regulatory subunit of R1 complexes HDAC3 (49) [43]
Variable third regulatory subunit of R2 complexes R3 (95) ﬂﬂ (109) Psy2p (98) [5,26]a
Gemin4 (120) [22]
NF-jB (65) [34,37]
The molecular mass of each subunit is given in kDa in parenthesis.
aMutations in the protein Falafel (ﬂﬂ) are reported at http://ﬂybase.net, by Zarske, M. and Hafen, E. (2003) Dros. Res. Conf. 44, 514A.
Fig. 1. The PPP phosphome. Phylogenetic tree, depicting the relationships between Homo sapiens (Hs, red), Drosophila melanogaster (Dm, blue) and
budding yeast Saccharomyces cerevisiae (Sc, brown) protein serine/threonine phosphatases in the PPP family. The unrooted tree is derived from
multiple alignment in CLUSTALW of the phosphatase catalytic domain [1].
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phosphatase associated protein), which had previously been
shown to associate with Sit4p, Pph21 and Pph22p in the ab-
sence of any other regulatory subunits during conditions of
optimal growth [21]. On the other hand, R1 and R2 are
likely to be a core regulatory subunits, such that the
Ppp4c–R1 and Ppp4c–R2 complexes may then interact with
a variable third subunit as observed for most PP2A com-
plexes that do not involve a4 [22,23]. Putative orthologues
of mammalian R2 were identiﬁed in several species including
D. melanogaster, C. elegans and S. cerevisiae, where the
orthologue was open reading frame (ORF) YBL046w,
termed R2/YBL046w in this review (Table 1) [18]. In S.cerevisiae, R2/YBL046w and a ORF YLN201c termed
Psy2 (for platinum sensitivity 2) were among several proteins
found in complex with Pph3p in each of two separate gen-
ome-wide proteome screens and they were the only two
Pph3-binding proteins identiﬁed that were common to both
screens [24,25]. A putative orthologue of Psy2p has been
identiﬁed in humans, termed R3, and shown to exist in a
complex with R2–Ppp4c [26]. Interestingly, the putative
orthologue of R3 (109 kDa) in D. melanogaster is the pro-
tein Falafel (ﬂﬂ, Table 1). Another possible variable subunit
associating with the human Ppp4c–R2 complex is Gemin4
(120 kDa) of the survival of motor neuron (SMN) complex
[22].
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Ppp4c dephosphorylates phosphoserine in several proteins
such as phosphorylase and casein that are unlikely to be in
vivo substrates [7,27,28]. Dephosphorylation of phosphothreo-
nine in the peptide substrate RRAT(p) VA has also been dem-
onstrated [7]. The substrate speciﬁcity proﬁle of Ppp4c is
similar but not identical to that for PP2Ac, with Ppp4c dis-
playing relatively higher activity towards the phosphothreo-
nine peptide substrate than casein. Like most serine/
threonine phosphatases and in contrast to many serine/threo-
nine kinases, the substrate speciﬁcity of Ppp4c is unlikely to
be primarily determined by the sequence surrounding the
phosphorylated residue in the substrate. More probably, the
speciﬁcity of Ppp4c for certain substrates will reside in interac-
tion with the regulatory subunits. Complexes of R1or R2 reg-
ulatory subunits with Ppp4c substantially decrease Ppp4c
activity, possibly because they induce narrow substrate speci-
ﬁcities, but more likely due to inhibition of the catalytic sub-
unit by the regulatory subunit [16,18]. The mechanisms for
activation of these two complexes are currently unknown,
but may be partly by binding of a third subunit.3. Role of Ppp4 in organelle assembly
3.1. Essential function of Ppp4 in centrosome maturation
The centrosome in metazoans comprises a pair of centrioles
surrounded by pericentriolar material. Prior to mitosis, the
centrosomes enlarge by recruiting extra pericentriolar material,
including proteins such as c-tubulin and polo like kinase
(PLK) and concomitantly microtubule nucleation activity in-
creases substantially. c-Tubulin is present in ring-shaped com-
plexes within the pericentriolar material from which
microtubules grow by polymerisation of a- and b-tubulin di-
mers. However, the processes that regulate the assembly of
the mature centrosome and microtubule nucleation are poorly
understood.
Disruption of the Ppp4c gene in D. melanogaster by P ele-
ment mutagenesis gave rise to a homozygous strain centro-
somes minus microtubules (cmm), which has a semi-lethal
phenotype with early embryos exhibiting a decreased amount
of Ppp4c mRNA and 25% of wild type Ppp4 protein [2].
Early cmm embryos developed areas where centrosomes dis-
played no radiating microtubules and the mitotic spindle was
either absent or aberrant and unconnected to the centrosome,
with a consequent block in mitosis. As c-tubulin is essential for
the nucleation of microtubules in Drosophila [29], decreased
immunostaining of c-tubulin at the centrosomes, but not glob-
ally in cmm embryos, suggests that Ppp4c may be required
for a conformational change of c-tubulin or relocation of c-
tubulin to the centrosomes in order that the nucleation of
microtubules can be initiated. In C. elegans, depletion by
RNA-mediated interference (RNAi) of Ppp4c encoded by
one of two Ppp4c genes in this organism, caused a similar
semi-lethal phenotype with aberrations in formation of spin-
dles in mitosis and also in sperm meiosis [3]. Localisation of
both c-tubulin and PLK to the pericentriolar material was se-
verely disturbed. Since, unlike the situation in most metazoans,
c-tubulin is not essential for the nucleation of microtubules in
C. elegans, the aberrant recruitment of c-tubulin and PLK to
the pericentriolar material suggests Ppp4c is required for the
maturation of the centrosome. The localisation of Ppp4c tothe centrosomes during mitosis in D. melanogaster and C. ele-
gans and to the pericentriolar material in human cells supports
this conclusion [2,3,7] and would argue against Ppp4 playing a
more distant role, for example in the transcription or splicing
of c-tubulin and PLK mRNAs. The asymmetric regulatory
subunit R2 has also been localised to the centrosome in human
cells [18], but it is not known whether the complex containing
Ppp4c and R2 is active and if so what substrate(s) are being
dephosphorylated. In addition to the centrosomal location, it
should be noted that Ppp4c and R2 are also found in the nu-
cleus and at low levels in the cytoplasm [7,18]. In yeasts, the
structure of the spindle pole body is rather diﬀerent from that
of metazoan centrosomes and to date there is no evidence that
Pph3 is required in these organisms for the nucleation of
microtubules or the assembly of the spindle pole body. Ppp4
also is not found at centrosomes in plants, having been local-
ised to plastids in Arabidopsis thaliana [30].3.2. Function of Ppp4 in the survival of motor neuron complex
and spliceosome assembly
Spinal muscular atrophy, a progressive neurodegenerative
disease, results from a defect in one of the genes encoding the
SMN protein [31]. Complexes that comprise several proteins
(includingGemin2/SIP1, a putative RNAhelicaseGemin 3, Ge-
mins 4 and 5 and Sm proteins) tightly associated with the SMN
protein have been identiﬁed [32]. These SMN multi-protein
complexes have been implicated in the assembly of small nucle-
ar ribonucleoproteins (snRNPs) and small nucleolar ribonu-
cleoproteins (snoRNPs) in the cytoplasm, their transport to
the nucleus and maturation in nuclear bodies, known as Cajal
or coiled bodies. SMN complexes may also be involved in the
generation of active spliceosomes in the Cajal bodies and recy-
cling snRNPs after each round of pre-mRNA splicing. Precisely
why a defect in general cellular function can have such a tissue
speciﬁc phenotype is unclear, but neurons that are transcrip-
tionally very active may be particularly sensitive to perturba-
tions in snRNP biogenesis and regeneration [33].
Employing a proteomic approach to identify Ppp4c–R2
interacting proteins, the presence of Gemins 3 and 4 in immu-
nopellets of Ppp4c–R2 from human embryonic kidney (HEK)
293 cells suggested that the Ppp4c–R2 complex may regulate
one or more function of the SMN complex in these cellular
processes [22]. Co-expression of Ppp4c and R2 in Hela cells en-
hanced the speed of translocation into the nucleus of a ﬂuores-
cently labelled Sm protein from the cytoplasm (where binding
of snRNAs and snoRNAs occurs to form nascent snRNPs and
snoRNPs). The ﬂuorescently labelled Sm protein localised to
Cajal bodies and then to the nucleolus more rapidly in the
presence of expressed Ppp4c and R2, than in the presence of
Ppp4c or R2 alone. At later times the Sm protein is seen in
interchromatin granules that are thought to be sites of pre-
mRNA spliceosomal activity. The studies implicated Ppp4
complexes in cytoplasmic assembly and/or enhanced move-
ment of snRNPs/snoRNPs through their nuclear sites of mat-
uration. The co-localisation of Ppp4c and R2 with the
ﬂuorescently labelled Sm protein in the nuclear Cajal bodies
and in the nucleolar Sm accumulations suggest that Ppp4c–
R2 remains associated with the SMN complex as it moves to
these sites, consistent with Ppp4c–R2 being involved in the
temporal progression of snRNPs and/or several processing
(dephosphorylation) steps as they mature. At present, it is
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but since Gemin 3 interacts directly with SMN and Gemin 4
binds indirectly to SMN through interaction with Gemin 3,
Gemin 4 (120 kDa) was suggested to act as a third variable
subunit in a Ppp4c–R2 complex. Interestingly, not only are
Gemins 3 and 4 associated with Ppp4c–R2 complexes but Ge-
min 5, a large tryptophan-aspartic (WD) repeat containing
protein, interacting directly with SMN, has also been identiﬁed
by mass spectrophotometric analysis in R2 immunopellets
(G.C. Carnegie and P.T.W. Cohen, unpublished data).4. Role of Ppp4 in cellular signalling
4.1. NF-jB pathway
Lipopolysaccharide (LPS) from bacterial infection, tissue
damage and tumourigenesis cause release of inﬂammatory
mediators, including cytokines and tumour necrosis factor
(TNFa) from various cell types. These agents lead to the acti-
vation of the transcription factor, nuclear factor-jB (NF-jB),
which thus plays a key role in immune and inﬂammatory re-
sponses and tumourigenesis. NF-jB is a heterodimer of two
related proteins of 65 and 50 kDa (p65, also called RelA,
and p50) and is present bound to an inhibitor I-jB in the cyto-
plasm in resting cells. Phosphorylation of I-jBa leads to its
degradation and unmasking of nuclear localisation sequences
on p65 and p50 that allow translocation followed by binding
to speciﬁc DNA sites, where NF-jB activates transcription.
In addition, NF-jB can be activated by phosphorylation at
several serine residues.
Ppp4c was identiﬁed in a two hybrid screen with c-Rel (a re-
lated NF-jB family member) as bait and was shown the bind
to c-Rel, NF-jB p65 and p50 by immunoprecipitation [34].
Overexpression of Ppp4c, but not presumed catalytically inac-
tive mutants of Ppp4c (R235L), Ppp4c (R325E), Ppp4c
(R235K) in HEK293 cells stimulated binding of c-Rel to
DNA containing NF-jB speciﬁc sequences and activated
NF-jB-mediated transcription. However, PP2A has previ-
ously been implicated in dephosphorylation of p65, which re-
sults in a decrease of transcriptional activity of NF-jB [35].
In contrast, TNFa is associated with an increase in transcrip-
tional activity of NF-jB and was observed to activate endog-
enous Ppp4c about 4-fold [36].
Anticancer drugs, such as cisplatin, also lead to the activa-
tion of NF-jB and this is associated with induced drug resis-
tance in some tumour cells. Suppression of extracellular
signal-regulated protein kinase-2 (ERK2) by MEK/ERK
inhibitors enhances cisplatin-induced resistance in SiHa cells
and further activates NF-jB. Recent studies show that
although cisplatin increased serine phosphorylation of NF-
jB p65, the drug resulted in dephosphorylation of threonine
[37]. Suppression of the MEK/ERK pathway further enhanced
Thr dephosphorylation but did not aﬀect cisplatin-induced Ser
phosphorylation of NF-jB p65. The threonine residue in-
volved is thought to be Thr435 and overexpressed Ppp4c de-
creased the phosphorylation of this amino acid. Ppp4c was
found to directly interact with NF-jB, although phosphoryla-
tion of Thr435 was not necessary for this interaction [34,37].
The protein level of nuclear Ppp4c was increased in cisplatin
treated cells and was further increased by suppression of the
MEK/ERK pathway. Thus, activation of NF-jB in response
to cisplatin and via suppression of the MEK/ERK pathwayis thought to be mediated via a Ppp4-catalysed dephosphoryl-
ation of Thr43in NF-jB p65, rather than by phosphorylation
of NF-jB on serine residues or via the more classical pathway
involving I-jB degradation [37]. Interestingly, these results
suggest that Ppp4 activation may underlie the increased resis-
tance of some tumour cells to cisplatin.
4.2. Jnk pathway
The c-Jun N-terminal kinase (Jnk) pathway may be acti-
vated by variety of signals including TNFa. Expression of
Ppp4c activated the Jnk pathway, while a dominant negative
mutant, blocked TNFa-induced activation of JNK, but no di-
rect interaction of Ppp4 and JNK was detected [36]. In haema-
topoietic cells, haematopoietic progenitor kinase 1 (HPK1) is a
known upstream kinase in the Jnk pathway that is implicated
in T cell receptor (TCR) signalling. In cells co-transfected with
HPK1 and Ppp4c, HPK1 was activated and an interaction of
Ppp4c with HPK1 detected was enhanced by TCR stimulation
[38]. Ppp4c was found to increase the half-life of HPK1 prob-
ably by inhibiting HPK1 ubiquitination and degradation. The
studies suggested Ppp4 may be involved in the positive regula-
tion of the HPK1-JNK signalling pathway [38]. However, in
order to verify the speciﬁcity of these interactions, it will be
necessary to show that endogenous HPK1 and endogenous
Ppp4c interact and that PP2Ac cannot substitute for Ppp4c.4.3. Apoptotic signalling
In order to identify novel proteins involved in the control of
apoptosis (programmed cell death), mouse thymoma cells in-
fected with retroviral cDNA library derived from haemopoi-
etic cells were screened for resistance to several apoptotic
stimuli [39]. A Ppp4c cDNA encoding amino acids 107–307
and encompassing the 3 0untranslated region (UTR) was iden-
tiﬁed. As the cDNA was missing the start codon and regions
coding for conserved catalytic residues, it was unlikely to sup-
port expression of active or inactive Ppp4c. T-lymphocytes
transfected with this partial Ppp4c cDNA were found to
down-regulate endogenous Ppp4c mRNA and protein levels
by about 50% and were resistant to apoptosis induced by both
dexamethasone and UV radiation, thus suggesting that Ppp4c
plays a proapoptotic role in these cells. The manner in which
the partial Ppp4c cDNA down-regulates Ppp4c is not known,
but the sense orientation of expression suggested a direct eﬀect
was unlikely and it was hypothesised that the 3 0UTR of the
partial Ppp4c cDNA may compete with the endogenous
Ppp4 mRNA 3 0UTR for factors controlling stability. How-
ever, such a mechanism could also aﬀect the stability of other
mRNAs. The means by which a decrease in Ppp4c confers
resistance to apoptosis in T-lymphocytes is unknown and
would appear to be in conﬂict with depletion of Ppp4c in em-
bryos of D. melanogaster and C. elegans, which decreases cell
survival (see Section 3.1).4.4. Signalling through IRS4
Insulin and insulin-like growth factor (IGF-1) exert their ef-
fects on cellular processes including glucose uptake, glycogen
synthesis and protein synthesis by binding to their tyrosine ki-
nase receptors, which undergo autophosphorylation. Insulin
receptor substrate proteins of which there are four (IRS1-4)
bind to the phosphorylated receptors. Tyrosine phosphoryla-
tion of the IRS proteins by the insulin or IGF1 receptor allows
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activation of the PKB signalling pathways. Using a proteomic
approach, Flag-Ppp4c was found to interact with IRS4 follow-
ing stimulation of HEK293 cells with TNF-a [40]. Ppp4c, but
not PP2Ac down-regulated IRS-4 and TNF-a stimulated deg-
radation of IRS-4 that was dependent on active Ppp4c and
blocked by inactive Ppp4c. Since TNF-a plays an inhibitory
role in insulin signalling and may contribute to the develop-
ment of insulin resistance, the TNF-a-induced degradation
of IRS-4 may be signiﬁcant. However, most serine phosphory-
lations in IRS-1 inhibit IRS-1-mediated insulin signalling, but
it is possible that dephosphorylation of one or more serine res-
idues in IRS-4 by Ppp4c may also inhibit insulin and or growth
factor signalling. The Ppp4c regulatory subunits R1 and R2
and a-4 were all found in Flag-Ppp4c immunopellets and it
would be interesting to know whether any of these are found
in IRS-4 immunoprecipitates and regulate the Ppp4 activity
in this system.
4.5. Target of rapamycin pathway
The target of rapamycin (TOR) signalling pathway regulates
growth in yeast, ﬂy and mammalian cells in response to nutri-
ents [41,42]. Rapamycin is a widely used immunosuppressant
and antineoplastic drug that inhibits the protein serine/threo-
nine kinases Tor1p and Tor2p in yeast and orthologous pro-
teins TOR1/2 in mammals. In S. cerevisiae, these kinases
respond to carbon and nitrogen availability by regulating sig-
nalling pathways that modify gene expression to maximise the
yeast cell potential for survival, growth and multiplication.
Gln3p is one of several GATA-type transcription factors
responsive to diﬀerent nitrogenous nutrients and starvation.
During availability of good nitrogen sources, Gln3p is re-
strained to the cytoplasm by Tor1p/Tor2p phosphorylation
and binding to Ure2p, which is also phosphorylated by theTor
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nase activity decreases and the ‘‘Tap42-dependent’’ phospha-
tases (Pph3, Sit4p, Pph21p and Pph22p) dephosphorylate
Ure2p and Gln3p, allowing Gln3p to translocate to the nu-
cleus. Gln3p binds to GATA-containing DNA sequence ele-
ments and activates the expression of genes such as GLN1
and GAP1 associated with transport, degradation and utilisa-
tion of poor nitrogen sources. The Tor kinases regulate the
‘‘Tap42-dependent’’ phosphatases by phosphorylating
Tap42p, to which the catalytic subunits bind only when
Tap42p is phosphorylated. Gln3p can be activated by rapamy-
cin inhibition of Tor kinases in wild type yeast and this activa-
tion is attenuated in pph3D yeast cells, where Pph3p is not
expressed [4]. These studies show that the function of Pph3p
in this pathway cannot be substituted by Sit4p, Pph21p or
Pph22p. A model for the involvement of Pph3 and its known
regulatory subunits in this pathway is presented (Fig. 2).5. Nuclear functions of Ppp4
Immunocytological analyses have shown that Ppp4 is pre-
dominantly located in the nucleus and the role of Ppp4 in
spliceosomal assembly (see Section 3.2) could account for this
subcellular location. However, other nuclear functions have
been reported.
5.1. Histone deacetylation of chromatin
Covalent modiﬁcations of chromatin, including acetylation
and phosphorylation, play important roles in regulating the
transcriptional and replication activities of chromatin. The
acetylation of lysine in the N-terminal tails of histones is a dy-
namic process maintained by histone acetyl transferases and
histone deacetylases (HDACs). HDACs form complexes withPph3
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Nucleus
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e nucleus where it will activate the transcription of genes required for
, the Pph3–R2 complex interacts with Psy2 and enters the nucleus to
s are written without the additional ‘‘p’’.
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scription by removing acetyl groups, allowing the positively
charged side chain of lysine to interact with the DNA.
HDAC3, which interacts with the co-repressors termed nuclear
hormone receptor corepressor (N-coR) and silencing mediator
for retinoid and thyroid hormone receptors (SMRT), was
found to co-purify with Pppp4c and its regulatory subunit
R1 [43].
Epitope tagged – HDAC captured R1 from an in vitro
translation system, as well as from an overexpression sys-
tem. HDAC was shown to be phosphorylated on Ser424 by
casein kinase2 (CK2) and mutation of this residue de-
creased HDAC activity. Overexpression of R1 and Ppp4c
together or Ppp4c alone speciﬁcally dephosphorylated this
residue in HDAC3 and depletion of Ppp4c in Hela cells
by RNAi increased the deacetylase activity of HDAC.
The studies indicate that Ppp4c–R1 is a negative regulator
of HDAC3 activity suggesting a role for this phosphatase
in the regulation of histone acetylation and chromatin
remodelling.5.2. Stabilisation of stalled replication forks
In response to DNA damage by irradiation or chemical
mutagens, DNA repair processes are initiated by a group of
genes called the RAD genes in S. cerevisiae. In addition to
DNA repair, the RAD52 set of genes are involved in repairing
stalled or collapsed replication forks. These arrested replica-
tion forks must also be maintained or stabilised while the
DNA is repaired so that they can eventually be restarted. In
order to identify proteins involved in the stabilisation of stalled
replication forks, a genome-wide screen in S. cerevisiae was
performed for genes whose deletion rendered yeast cells sensi-
tive to low intensity, chronic UVB radiation but did not cause
cell death [44]. This led to the isolation of the WSS1 gene.
Binding partners for Wss1p identiﬁed in a two-hybrid screen
were Tof1p, a protein previously known to be involved in sta-
bilisation of replication forks, and Psy2p and a protein that
interacts with Pph3 [24,25] and is sensitive to DNA-binding
drugs (see below). Based on the idea that Wss1p, Psy2p and
Tof1 may stabilise or process stalled replication forks, the ef-
fect of crippling the DNA damage repair pathways by deleting
RAD52 was examined. The double deletion mutant psy2D
rad52D was more sensitive to DNA damage than predicted
from the sensitivities of the two single mutants. WSS1 and
TOF1 also showed similar genetic interactions with RAD52
in response to DNA damage. These studies implicate Wss1p,
Tof1p and Psy2p in maintenance of stalled or collapsed repli-
cation forks, rather than DNA repair. As Psy2p would appear
to be a third subunit of Pph3p, binding to the Pph3p–R2/
YBL046w complex, the data uncover a role for the Pph3 com-
plex and probably its mammalian Ppp4–R2–R3 complex in
stabilisation of stalled replication forks during the DNA dam-
age response.5.3. Establishment or maintenance of chiasmata
In C. elegans, depletion of Ppp4c not only disrupted centro-
somal maturation but also decreased the number of chiasmata
seen between homologous chromosomes during meiosis in oo-
cytes. The observations suggest Ppp4c may play a role in the
formation or maintenance of chiasmata during chromosomal
recombination in oocytes [3].6. Sensitivity of Ppp4 to toxins and antitumour agents
6.1. Inhibition of Ppp4 by toxins
Ppp4 is potently inhibited by a variety of naturally occurring
toxins and tumour promoters that possess diverse primary
structures. Microcystins produced by cyanobacteria are cyclic
heptapeptide toxins, and okadaic acids produced by marine
dinoﬂagellates are polyether fatty acids. Nevertheless, these
compounds and others such as calyculin A inhibit members
of the PPP family in a similar manner by insertion of a carbox-
ylate group into the catalytic site which binds the substrate-
phosphate [45]. Microcystin-LR, okadaic acid, calyculin A
and tautomycin all inhibit Ppp4c with an IC50 in the subn-
anomolar range [27]. These inhibition characteristics are indis-
tinguishable from those for PP2Ac and might be expected to
be similar for Ppp6c for which detailed information is not
available. PP1c can be distinguished in that its IC50 for okadaic
acid is 100-fold higher than those Ppp4 and PP2A, while cal-
cineurin/PP2B and Ppp7 are not inhibited by these toxins.
Ppp5 on the other hand exhibits IC50 values for these toxins
that are only slightly higher than those for Ppp4 and PP2A
[46,47]. Many previous studies relied on the use of okadaic
acid to show the involvement of PP2A in cellular processes,
but because okadaic acid inhibits Ppp4, PP2A and Ppp5 with
comparable IC50 values, it will be necessary to re-examine
some of the functions assigned to PP2A. Okadaic acid may
act as a tumour promoter or tumour suppressor depending
on the concentration, duration of treatment and type of cells
being treated.
6.2. Inhibition of Ppp4 by the antitumour agents cantharidin and
fostriecin
Cantharidin, initially obtained from the Chinese blister bee-
tle, has been used to treat warts, and cancers for over 2000
years, but its marked toxicity has limited its general use in
oncology. Cantharidin inhibits Ppp4c, PP2Ac and Ppp5 with
an IC50 of50 nM and is at least 10-fold less potent on catalytic
subunits of PP1 and calcineurin/PP2B [27,46]. In mammalian
cell lines, treatment with cantharidin results in a G2/M-phase
arrest with the formation of aberrant mitotic spindles, prior
to the induction of apoptosis, shown to be dependent on the
presence of the p53 gene [48]. Deﬁciency of PP2Ac in D. mela-
nogaster microtubule star (mts) embryos is associated with the
uncoupling of nuclear and centrosome cycles with the forma-
tion of elongated microtubules and multiple centrosomes [49],
in contrast to deﬁciency of Ppp4c inD. melanogaster andC. ele-
gans, which blocks the formation of the mitotic spindle (Section
3.1). The observed eﬀects of cantharidin on microtubules and
centrosomes may therefore result from the inhibition of both
PP2Ac and Ppp4c.
Fostriecin was discovered during a tumour cell screening
program designed to identify new antineoplastic agents from
Streptomyces pulveraceus (subspecies fostreus). Although fost-
riecin was initially thought to be a topoisomerase II inhibitor,
subsequent studies showed that it was a more potent inhibitor
of inhibitor of the PPP phosphatases [50]. It inhibited Ppp4c
with an IC50 of 3 nM that was similar to that for PP2Ac and
was 1000-fold less potent on PP1c, Ppp5 and calcineurin/
PP2B [27,47]. Like cantharidin, fostriecin induced a G2/M-
phase arrest with the formation of aberrant mitotic spindles
in mammalian cell lines. At much higher concentrations (25–
500 lM) it induced apoptotic cell death [48].
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Fig. 3. Ppp44 complexes regulating mammalian functions.
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concerned mainly with its stability led to termination of the
tests.
6.3. Pph3 confers resistance to the anticancer DNA-binding
drugs, cisplatin and oxaliplatin
Cisplatin and oxaliplatin are potent chemotherapeutic
agents currently used in the treatment of many cancers, includ-
ing lung, gonadal, head, neck and bowel neoplasias. Cisplatin
forms adducts with DNA and induces intrastrand cross-links
that result in activation of DNA repair processes that eventu-
ally lead to apoptotic cell death. A genome-wide screen of S.
cerevisiae genes that, when individually deleted, conferred sen-
sitivity to cisplatin and oxaliplatin, identiﬁed among the top 20
most sensitive genes PPH3 and a gene of unknown function
YNL201c that the authors termed PSY2 (for platinum sensit-
ivity 2) [5]. As mentioned above (Section 2.2), R2/YBL046w
forms a direct interaction with Pph3p and the trimeric complex
Ppp4c–R2–R3 is found in higher organisms [26]. Psy2p and
R2/YBL046w were among several proteins found in complex
with Pph3p in each of two separate genome wide two hybrid
screens [24,25]. However, a strain deleted for R2/YBL046w
was not identiﬁed as sensitive to cisplatin and oxalyplatin.
Nevertheless, our initial studies indicate that deletion of R2/
YBL046w results in a similar increase in sensitivity to cisplatin
as deletions of Pph3p and Psy2p, indicating that the human
complex Ppp4c-R2-R3 orthologous to the yeast trimeric com-
plex Pph3–R2/YBL046w–Psy2 is likely to confer resistance to
cisplatin [26].7. Conclusions and perspectives
Recent studies have shown that Ppp4 regulates an increasing
number of cellular functions (Fig. 3). The identiﬁcation of sev-
eral regulatory subunits speciﬁc to Ppp4 and its yeast homo-
logue Pph3, together with the variety of processes regulated
in diﬀerent subcellular locations indicates that, like other pro-
tein serine/threonine phosphatases, Ppp4 is probably targeted
to its speciﬁc sites of action by these regulatory subunits. At
present, it is unclear how the activity of Ppp4 complexes is reg-ulated, but the interchange between the diﬀerent regulatory
subunits will undoubtedly play a part. Carboxymethylation
of Ppp4c and covalent modiﬁcation of the regulatory subunits
may inﬂuence which regulatory subunit(s) are bound the cata-
lytic subunit. Phosphorylation of one regulatory subunit
(Tap42p), which Pph3p shares with Pph21/22p and Sit4p,
has been implicated in activation of these phosphatases. Three
direct substrates of Ppp4/Pph3 (NF-jB, HDAC3 and Tap42)
that may also qualify as regulatory subunits have been re-
ported, but future studies should identify more speciﬁc sub-
strates of Ppp4, the mechanisms that are involved in the
binding of diﬀerent regulatory subunits and how these aﬀect
Ppp4 activity. The roles of Ppp4 in organelle assembly and
how the Pph3p trimeric complex and the orthologous mamma-
lian Ppp4 complex may confer resistance to anticancer DNA-
binding agents will be interesting areas of future research.
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